Compare RPID & CFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RPID | CFBK |
|---|---|---|
| Founded | 2006 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 178.6M | 167.9M |
| IPO Year | 2021 | 1998 |
| Metric | RPID | CFBK |
|---|---|---|
| Price | $3.24 | $26.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | $8.00 | ★ $29.00 |
| AVG Volume (30 Days) | ★ 159.8K | 73.9K |
| Earning Date | 02-27-2026 | 02-11-2026 |
| Dividend Yield | N/A | ★ 1.41% |
| EPS Growth | N/A | ★ 21.79 |
| EPS | N/A | ★ 2.49 |
| Revenue | $30,523,000.00 | ★ $50,724,000.00 |
| Revenue This Year | $19.36 | $39.98 |
| Revenue Next Year | $21.48 | $10.47 |
| P/E Ratio | ★ N/A | $10.24 |
| Revenue Growth | ★ 16.63 | 14.25 |
| 52 Week Low | $0.98 | $19.23 |
| 52 Week High | $4.50 | $27.46 |
| Indicator | RPID | CFBK |
|---|---|---|
| Relative Strength Index (RSI) | 47.95 | 70.46 |
| Support Level | $2.70 | $24.32 |
| Resistance Level | $3.45 | $26.46 |
| Average True Range (ATR) | 0.23 | 0.78 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 65.00 | 87.92 |
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.